Outlook Therapeutics Inc. (OTLK) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Outlook Therapeutics Inc.

    NASDAQ: OTLK · Real-Time Price · USD
    0.97
    -0.00 (-0.40%)
    At close: Sep 26, 2025, 3:59 PM

    Outlook Therapeutics Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 113.86K 44.19K 204.69K 262.14K
    Gross Profit
    		 -113.86K -44.19K -204.69K -262.14K
    Operating Income
    		 -71.7M -53.13M -63.07M -51.73M
    Interest Income
    		 906.15K n/a n/a n/a
    Pretax Income
    		 -75.36M -58.98M -66.05M -53.16M
    Net Income
    		 -75.37M -58.98M -66.05M -53.16M
    Selling & General & Admin
    		 29.94M 26.67M 20.74M 12.77M
    Research & Development
    		 41.76M 26.45M 42.33M 38.96M
    Other Expenses
    		 n/a n/a -205K n/a
    Operating Expenses
    		 71.7M 53.13M 62.87M 51.73M
    Interest Expense
    		 3.16M 1.56M 1.49M 936.13K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 71.7M 53.13M 63.07M 51.73M
    Income Tax Expense
    		 2.8K 2.8K 2.8K 2K
    Shares Outstanding (Basic)
    		 18.55M 12.51M 10.6M 7.63M
    Shares Outstanding (Diluted)
    		 18.55M 12.51M 10.6M 7.63M
    EPS (Basic)
    		 -4.06 -4.72 -6.23 -6.96
    EPS (Diluted)
    		 -4.06 -4.72 -6.23 -6.96
    EBITDA
    		 -72.09M -57.38M -64.36M -51.51M
    EBIT
    		 -72.21M -57.42M -64.56M -51.73M
    Depreciation & Amortization
    		 113.86K 44.19K 204.69K 262.14K

    Add to Watchlist